Willis Towers Watson, GB00BGSZ2X45

Resilient Willis Towers Watson stock edges higher as analyst targets rise

Published on 08/19/2026 at 19:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Willis Towers Watson stock trades around $327 with a modest gain as fresh analyst targets point to upside and consensus expectations remain supportive of the insurance broker’s 2026 outlook.

Pop-Art-Comic: Handschlag zwischen Berater und Kunde, Sprechblase mit Häkchen
Willis Towers Watson (GB00BGSZ2X45) als Pop-Art-Comic: fröhlicher Versicherungsmakler schüttelt Kundenhand im bunten, modernen Büro, Illustration mit AI erstellt.

Willis Towers Watson Public Limited Company (ISIN GB00BGSZ2X45) stock is trading around $327.90 as of August 18, 2026, reflecting a 0.56% gain on the latest Nasdaq close and signaling steady investor confidence in the global insurance and consulting group.

The latest market data as of the August 18, 2026, close show Willis Towers Watson shares ending the regular session at $327.88 to $327.90, with the price up $1.82 or 0.56% on the day and extending a recent upward trend for the stock.

Intraday data compiled on August 19, 2026, indicate that during the most recent trading session the shares moved between a low of $327.78 and a high of $333.65, placing the current $327.90 level 1.7% below that session’s high and slightly above the session low.

Analyst targets lift upside expectations

Per a recent analyst update reported on August 19, 2026, one major Wall Street firm lifted its price target on Willis Towers Watson stock from $315 to $350 while maintaining an equalweight stance, underscoring a view that the shares have room to advance but are not seen as deeply undervalued at current levels. The price-target adjustment article notes that with the latest close at $327.90, the new $350 target implies upside of roughly $22 per share.

Recent consensus data indicate that the broader analyst community continues to see the valuation favorably, with Willis Towers Watson carrying a consensus rating described as moderate buy and an average price target of $365.38 according to one aggregated coverage overview. That consensus snapshot suggests that on the August 18, 2026, closing price of $327.90, the average target embeds potential upside of $37.48 per share.

Another forecasting overview focused on Willis Towers Watson’s sector context places the average price target for the shares at $370.00, with a high estimate of $400.00 and a low of $303.00, highlighting a broad but generally positive range of expectations for the insurance broker. This forecast distribution shows the average target of $370 versus the recent close near $327.88, implying an upside spread of $42.12 if the shares were to reach that central estimate.

Market performance and valuation context

According to a recent valuation-focused article, Willis Towers Watson shares at $327.90 are associated with a market capitalization of $30.46 billion, reflecting the sizeable scale of the company in the global insurance and risk advisory landscape. The same market snapshot shows that at the August 19, 2026, trading session the stock’s move between $327.78 and $333.65 kept the price fractionally above the intraday low and 1.7% below the high, suggesting limited volatility over the course of the day.

A separate performance-focused note describes Willis Towers Watson trading at $327.90 with a 30 day share price return of 11.75% and a 90 day share price return of 29.07%, signaling a strong multi-week and multi-month trajectory for the stock. This analysis highlights that the company’s fair value is estimated at $374.74 based on a discounted cash flow approach with a 7.65% discount rate, positioning the current share price modestly below that modeled intrinsic valuation.

Short-term trading data reveal an additional dimension of investor sentiment, with one real-time quote at 12:44 p.m. Eastern on August 19, 2026, showing Willis Towers Watson stock changing hands at $335.17, up $7.27 or 2.22% on the day according to an intraday feed. That intraday quote illustrates that the shares continue to see active buying interest, with the price pushing above the previous closing range and approaching the lower end of analysts’ target spectrum.

From a broader perspective, one forecast overview scores Willis Towers Watson’s earnings outlook at 7.58, ranking the company 36th out of 116 insurers in its peer set, and reiterates an average price target of $370.00 with a high of $400.00 and a low of $303.00. This peer-relative ranking suggests that while the company is not at the top of its sector in terms of projected earnings growth, it still occupies a favorable position within the broader insurance industry.

Consensus and guidance backdrop

Extended-hours trading data as of August 19, 2026, give an additional lens on near-term positioning, with a forecast and price-target page reporting Willis Towers Watson at a regular-session close of $327.90 and an extended trading quote of $330.00, up $2.10 or 0.64%. This combined quote and forecast overview underscores that investors are willing to pay a modest premium over the official close in electronic after-hours trading.

The same forecast material emphasizes that the stock’s recent move has taken place against the backdrop of structured earnings expectations, including forward estimates for revenue and earnings per share, although the detailed quarterly figures are not fully disclosed in the snippets. The earnings projection page indicates that analysts foresee continued growth in Willis Towers Watson’s key financial metrics, supporting the positive tilt in price targets.

Historical dividend and event data from the company’s listing history show past cash dividends and corporate actions, reinforcing Willis Towers Watson’s profile as a mature business with an established capital-return track record. The dividend and split timeline lists prior payouts and structural share changes, though the latest snippets focus more on current pricing than on detailed dividend yields.

Investors watching Willis Towers Watson stock can therefore frame today’s modest price gains against a backdrop of supportive analyst consensus, a fair value estimate above the current trading level, and multi-month share price momentum that has significantly outperformed over the past 90 days.

Advisory and benefits product focus

Within Willis Towers Watson’s broad portfolio, a representative offering is its employee benefits and risk consulting services, which bring together insurance brokerage, benefits design, and analytics to help large employers manage healthcare costs, retirement obligations, and workforce risk. These solutions typically involve advising clients on plan design, negotiating with insurers and service providers, and using data-driven tools to identify cost drivers and risk concentrations.

For corporate clients, Willis Towers Watson’s benefits and advisory products are designed to improve the sustainability of pension schemes and health plans while maintaining competitiveness for talent. By tailoring benefits structures to local regulations and market practices across regions, the company aims to balance cost efficiency with employee engagement.

The advisory work often extends to specialized risk consulting, where Willis Towers Watson helps organizations assess exposures ranging from property and casualty risks to cyber threats and executive liability. Through a mix of quantitative modeling and scenario analysis, these services support decisions on insurance coverage levels, self-retention, and alternative risk-transfer solutions.

The company’s analytics capabilities underpin many of these products, integrating actuarial expertise with predictive tools that process claims data, demographic trends, and economic assumptions. For clients, this can translate into more precise budgeting for benefits and insurance programs, as well as clearer visibility into the long-term impact of strategic decisions on workforce well-being and corporate financials.

Shares and recent trading

As of the regular Nasdaq session close on August 18, 2026, Willis Towers Watson stock finished at $327.88 to $327.90 USD, with the quote feed showing the price up $1.82 or 0.56% on the day and extending a recent positive streak in the shares. The closing price snapshot indicates a stable trading pattern, with quotes delayed by 15 minutes, typical for consolidated market data.

Given a market capitalization stated at $30.46 billion as of that pricing, Willis Towers Watson commands a significant presence on the Nasdaq exchange in the insurance and advisory space. With analysts’ average price targets ranging from $365.38 to $370.00 and high targets reaching $400.00, the gap between current trading levels and these expectations remains a central point of interest for investors evaluating potential upside.

Read more

More on Willis Towers Watson stock

Investor Relations

Investor Relations

Key product: benefits and risk advisory

Willis Towers Watson’s benefits and risk advisory services offer comprehensive support for employers looking to manage healthcare and retirement programs, negotiate insurance coverage, and quantify complex risk exposures across global operations.

Share performance and valuation signal

With Willis Towers Watson stock quoted at around $327.90 as of August 18, 2026, and intraday trading on August 19, 2026, showing moves into the mid-$330s, the shares currently trade below multiple analyst targets and below one modeled fair value estimate of $374.74, suggesting that investors continue to weigh upside potential against sector risks.

Fact box

Company: Willis Towers Watson Public Limited Company

ISIN: GB00BGSZ2X45

Ticker: WTW

Exchange: Nasdaq

Price (as of August 18, 2026, 4:00 p.m. ET): $327.88 USD

Market cap: $30.46 billion (as of August 19, 2026)

Sector / Industry: Insurance brokerage and risk consulting

Index membership: S&P 500

Disclaimer...

en | GB00BGSZ2X45 | WILLIS TOWERS WATSON | boerse | 69971872 | bgmi